SCHEMBL4977246

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL4972124	0.90	KDR (0.47)	METPDPK1KLKB1KIT
	SCHEMBL5423013	0.85	KDR (0.51)	GAACSF1RKIT
	SCHEMBL4970611	0.84	PDPK1 (0.42)	METPDPK1KLKB1KIT
	SCHEMBL4974499	0.83	DHPS (0.44)	METPDPK1NPC1RAB9A
	SCHEMBL4977706	0.82	KDR (0.49)	METPDPK1
	SCHEMBL4975671	0.82	MET (0.42)	METPDPK1KIT
	SCHEMBL4970131	0.81	KDR (0.45)	MET
	SCHEMBL4974261	0.81	KDR (0.44)	METPDPK1KLKB1
	SCHEMBL4978486	0.81	KDR (0.51)	METTRPV1KIT
	SCHEMBL4971833	0.80	MET (0.45)	METPDPK1KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.